In a study online in the Journal of Medicinal Chemistry Vern L. Schramm, Ph.D., and colleagues report developing molecules that—when added to BRCA-deficient tumors that had become resistant to PARP inhibitors—restored the tumors’ sensitivity to the inhibitors.

#BCSM #BRCA #cancer #SciSky